Lowenstein Sandler represented Twill, Inc., a leader in digital-led care, in its sale to DarioHealth Corp. (NASDAQ: DRIO).
The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions. The transaction creates immediate scale, with three of the top eight national health plans, multiple Fortune 100 employers and several major pharmaceutical companies as customers.
Dario is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Twill offers a digital solution optimized for mental health and resiliency with tailored and culturally adapted tracks and activities.
The Lowenstein deal team includes: Michael J. Lerner, Annie Nazarian Davydov, Park S. Bramhall, Bryan A. Weisgal, Andrew E. Graw, Sophia Mokotoff, Raquel Smith, Tracy F. Buffer, and Crystal McDonald.
